Document Detail

Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
MedLine Citation:
PMID:  10884579     Owner:  NLM     Status:  MEDLINE    
A macromolecular prodrug of methylprednisolone (MP) was synthesized by conjugating MP with dextran with a M(W) of 70000 through a succinic acid linker. It has been shown previously that the dextran-MP conjugate (DMP) releases MP directly or indirectly through formation of methylprednisolone succinate (MPS) which is further hydrolyzed to MP. To investigate the suitability of DMP conjugate as a prodrug of MP for systemic administration, the kinetics of hydrolysis of the conjugate was studied in vitro in rat blood and liver lysosomes. In blood, the hydrolysis of MPS to MP was approximately ten-fold faster than that in buffer. However, the hydrolysis rate constants of DMP conjugate to MP or MPS in blood were not different from those in buffer. Overall, the hydrolysis of DMP in the rat blood occurred with a half life of approximately 25 h. Hydrolysis of MPS to MP also occurred in the liver lysosomal fraction, but not in the control samples lacking lysosomes. However, the rate constants for the hydrolysis of DMP conjugate to MP and MPS in the lysosomal fraction were not significantly different from those in the control samples. These data suggest that the slow hydrolysis of DMP conjugate to MP or MPS in both rat blood and liver lysosomes occurs mostly, if not completely, via chemical hydrolysis. However, the conversion of MPS to MP is apparently enzymatic. The data may have significant implications for systemic administration of the prodrug.
R Mehvar; R O Dann; D A Hoganson
Related Documents :
3676279 - Phosphatidylinositol anchor of hela cell alkaline phosphatase.
863339 - Seasonal changes in the histoenzymatic distribution of acid and alkaline phosphatases a...
8907539 - Biochemical changes during regeneration of sunflower (helianthus annuus l.).
19404779 - Identification of chaulmoogric acid as a small molecule activator of protein phosphatas...
20488059 - Quantification of acetylcholinesterase, acid and alkaline phosphatases in the central n...
8780019 - Effects of the phosphatase inhibitors calyculin a and okadaic acid on acetylcholine syn...
9144299 - Oesophageal acid and salivary secretion: is chewing gum a treatment option for gastro-o...
18722649 - Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical...
10743819 - Excitatory amino acid profiles of synovial fluid from patients with arthritis.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of controlled release : official journal of the Controlled Release Society     Volume:  68     ISSN:  0168-3659     ISO Abbreviation:  J Control Release     Publication Date:  2000 Jul 
Date Detail:
Created Date:  2000-09-05     Completed Date:  2000-09-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8607908     Medline TA:  J Control Release     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  53-61     Citation Subset:  IM    
School of Pharmacy, Texas Tech University Health Sciences Center, 1300 Coulter, Amarillo, TX 79106, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dextrans / blood,  pharmacokinetics*
Liver / metabolism*
Lysosomes / metabolism*
Macromolecular Substances
Methylprednisolone Hemisuccinate / blood,  pharmacokinetics*
Prodrugs / pharmacokinetics*
Rats, Sprague-Dawley
Grant Support
Reg. No./Substance:
0/Macromolecular Substances; 0/Prodrugs; 2921-57-5/Methylprednisolone Hemisuccinate; 9004-54-0/Dextrans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethyle...
Next Document:  Sustained release of silver from periodontal wafers for treatment of periodontitis.